Abstract:Background Immunoglobulin (Ig) G4-related disease (IgG4-RD) is an increasingly recognized systemic autoimmune disease in the past decade, and encompasses a wide spectrum of disorders previously considered to be unrelated, but with common pathologic, serologic, and clinical features.There have been several hundred literatures on IgG4-RD published in the past few years, however, we still cannot well characterize this complicated disease, including clinical features, treatments as well as mechanisms, which promotesus to further describe this disease. Objectives To describe the clinical presentations, laboratory features, imaging manifestations, treatments and evolutions in a cohort of 34 Chinese patients with immunoglobulin G-related diseases (IgG4-RD). Methods A retrospective study was performed in Wuhan Tongji Hospital. Electronically stored records of clinical, laboratory, imaging, and histological features were reviewed. The diagnoses were made according to comprehensive diagnostic criteria for IgG4-RD. Disease activity was assessed by IgG4-RD Responder Index (RI).This study was approved by the Ethical Committee of TongjiHospital (TJ-C20150603). All patients were contacted, and consents were obtained from all the participants. Results We found that among the whole 34 patients enrolled in this study (median age=51 years, male/female ratio=1.4/1), 65.2% tested patients had a declined HDL level, 82.3% tested patients had an elevated IgG4 level, and lymph node was the most frequently involved organ. 18F-FDG PET/CT had high sensitivity in providing information about the organ distribution of IgG4-RD. The IgG4 level and IgG4-RD RI in the multi-organs affected patients were significantly higher than that in the localized ones. Most patients were prescribed with glucocorticoids (GCs) alone or combined with disease modifying antirheumatic drugs (DMARDs), the majorities responded well, while some relapsed. Patients given rituximab (RTX) obtained good responses. Conclusions It was concluded that 18F-FDG PET/CT can be an effective tool to detect involved lesions of IgG4-RD. The addition of DMARDs to the initial GCs therapy in the remission induction stage may not bring much benefit. The most appropriate dosage schedule of RTX needs to be further investigated. Patients with younger age, longer duration of disease, higher IgG4 level and IgG4/IgG ratio may more commonly experience recurrence. References Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med, 2001,344(10):732–738. Islam AD, Selmi C, Datta-Mitra A, et al. The changing faces of IgG4-related disease: Clinical manifestations and pathogenesis. Autoimmun Rev, 2015,14(10):914–922. Martinez-de-Alegria A, Baleato-Gonzalez S, Garcia-Figueiras R, et al. IgG4-related Disease from Head to Toe. Radiographics, 2015,35(7):2007–2025. Disclosure of Interest None declared

Current approach to the diagnosis of IgG4-related disease – Combination of comprehensive diagnostic and organ-specific criteria

Immunoglobulin G4-related Disease with Multiple Organs Involvement Depicted on FDG PET/CT: A Case Report and Literature Review.

Proposal of Diagnostic Criteria for IgG4-related Thyroid Disease

Comparison of IgG4-Related Lymphadenopathy and Multicentric Castleman's Disease: a Retrospective Study.

FRI0622 A Retrospective Cohort Study about the Clinical Characteristics of Igg4-Related Diseases

IgG4-related Autoimmune Pancreatitis,Hepatopathy and Sclerosing Cholangitis:Advances in Pathogenesis, Diagnosis and Treatment

Deciphering Three Predominant Biopsy-Proven Phenotypes of IgG4-associated Kidney Disease: a Retrospective Study

Clinical Profile of IgG4-related Disease in Japan Based on the Rare Disease Data Registry.

Validation of the Diagnostic Criteria for IgG4-Related Periaortitis/Periarteritis and Retroperitoneal Fibrosis (IgG4PA/RPF) 2018, and Proposal of a Revised 2023 Version for IgG4-Related Cardiovascular/Retroperitoneal Disease

Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020 (Revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012)

Clinical diagnostic criteria for IgG4‐related sclerosing cholangitis 2020

Diagnosis and Differential Diagnosis of Immunoglobulin G4-related Hepatobiliary Disease

Assessing IgG4-related ophthalmic disease and its mimics: a comparison of ACR/EULAR, organ-specific and revised comprehensive diagnostic criteria

Update on classification, diagnosis, and management of immunoglobulin G4-related disease

Comparative Analysis of Classification Criteria in IgG4-Related Disease and Evaluating Diagnostic Accuracy from Retrospective Cohort in Clinical Practice

American College of Rheumatology and the European League Against Rheumatism classification criteria for IgG4-related disease: an update for radiologists

Highlighting the importance of early diagnosis in progressive multi-organ involvement of IgG4-related disease: A case report and review of literature.

Nationwide epidemiological survey of immunoglobulin G4-related disease with malignancy in Japan

Highlighting the Importance of Early Diagnosis in Progressive Multi-Organ Involvement of IgG4-related Disease: A Case Report and Review of Literature

The immunological pathogenesis of IgG4-related disease categorized by clinical characteristics

The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease